Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 4, Number 1—March 1998
Letter

Mycobacterium nonchromogenicum Bacteremia in an AIDS Patient

On This Page
Article Metrics
12
citations of this article
EID Journal Metrics on Scopus

Cite This Article

To the Editor: Mycobacterium avium complex is the most common nontuberculous mycobacterium that causes disseminated infection in HIV-positive patients (1). Other less common nontuberculous mycobacteria responsible for disseminated disease in these patients are M. fortuitum (2), M. genavense (3), M. gordonae (4), M. haemophilum (5), M. kansasii (6), M. malmoense (7), M. marinum (8), M. scrofulaceum (9), M. simiae (10), M. szulgai (11), M. terrae (9), and M. xenopi (2,9). Although only M. genavense, M. kansasii, and M. xenopi are significantly more frequent in these patients (2,3,9), HIV infection is likely a predisposing condition for all nontuberculous mycobacterial infections. We report the first case of disseminated infection caused by M. nonchromogenicum in an HIV-infected patient.

A 28-year-old man with HIV infection acquired by sharing injection tools was seen in our outpatient clinic because of intermittent fever, drenching nocturnal sweats, and cough with purulent sputum of 4 months' duration. He also reported a weight loss of 10 kg in the previous 2 months. He had been treated for bronchial infection with an unknown antibiotic in another hospital. After this treatment, respiratory symptoms had improved somewhat, but fever and constitutional symptoms continued. His only previous opportunistic infection had been recurrent oral and esophageal candidiasis. The last CD4-cell count had been 16/µL 1 year earlier, and he was receiving didanosine and prophylactic therapy with cotrimoxazole and fluconazole. On physical examination the patient appeared ill; he was febrile, cachectic, and had thrush and oral hairy leukoplakia. Neither lymphadenopathy nor abnormal cardiopulmonary symptoms were found. The liver, which had enlarged since the last examination, was palpated 6 cm below the right costal margin. Abnormal laboratory values included aspartate aminotransferase 61 U/L, gamma-glutamyl transferase 209 U/L, lactate dehydrogenase 516 U/L, hemoglobin 12.3 g/dL, leukocyte count 4,300/µL (66% neutrophils, 19% band forms, 1% metamyelocytes, 3% lymphocytes, 11% monocytes), platelet count 130,000/L, and erythrocyte sedimentation rate 72 mm/h. Chest X-rays were unremarkable, and a set of blood cultures was sterile. A sputum culture yielded Haemophilus influenzae sensitive to ampicillin, and smears and cultures for mycobacteria in one stool and three sputum samples were negative.

The patient was treated with oral amoxicillin for 2 weeks without improvement. Empirical therapy against M. avium complex with clarithromycin, ciprofloxacin, and ethambutol was started; the patient's condition improved dramatically within the next few days, and the fever and diaphoresis disappeared, although cough and sputum production remained unchanged. Three weeks later, a slow-growing nonphotochromogenic mycobacterium, identified as M. nonchromogenicum in a reference laboratory (Centro Nacional de Microbiología, Majadahonda, Madrid, Spain) by biochemical tests and confirmed by polymerase chain reaction-restriction enzyme pattern analysis, was isolated from a blood sample obtained on admission. This microorganism was sensitive to the three drugs administered, and the treatment was continued. Two months later the patient had gained 10 kg, hemoglobin had increased to 13.8 g/dL, the erythrocyte sedimentation rate had decreased to 52 mm/h, and the differential leukocyte count had returned to normal. Antimycobacterial drugs were withheld after 1 year of treatment. Twenty-two months after the diagnosis, the patient is doing well. He is receiving combination antiretroviral therapy, and his CD4-cell count is 128/µL.

M. nonchromogenicum, a slow-growing nonpigmented (Runyon's group III) mycobacterium, belongs to the M. terrae complex, together with M. triviale; it is traditionally considered nonpathogenic. However, it has been involved in a few cases of pulmonary infection (12) and chronic tenosynovitis secondary to puncture wounds (13), like the related organism M. terrae. In fact, some authors think that M. nonchromogenicum is the true pathogen in the M. terrae complex (13), and it is possible that some reports have misidentified this organism. This complex was first isolated in soil washings from radishes, but it has been found to be ubiquitous in the aquatic environment, including a hospital potable water supply (14).

Unlike osteoarticular infections, which commonly occur in previously healthy people, the scanty reports on pulmonary and disseminated infection by M. terrae complex suggest that either immunosuppression or local predisposing conditions (e.g., tuberculous cavities) are necessary pathogenetic cofactors (15). To our knowledge, M. nonchromogenicum bacteremia has never been reported before.

No specific DNA probes exist for M. terrae complex, but false-positive reactions with M. tuberculosis complex DNA probes have been described (16). Isolates are usually resistant to most antituberculosis drugs, with the exception of ethambutol and streptomycin, and susceptible to erythromycin, ciprofloxacin, and sulfonamides.

Only one case of disseminated infection by M. terrae has been described in a patient with advanced HIV infection and positive cultures in blood and bronchoalveolar lavage fluid, but no additional data were provided (9). Although the isolate we recovered might represent a laboratory contaminant, several pieces of evidence make this possibility very unlikely: lack of alternative explanation for a persistent and progressive clinical picture of 4 months' duration, absence of response to standard antibiotic therapy, negative results in the search for other pathogens, rapid and sustained clinical and laboratory response to drugs active against this strain, clear improvement despite the lack of treatment for other conditions, and absence of other isolates of this pathogen in our hospital despite the large number of samples examined for mycobacteria.

Top

Acknowledgment

We are indebted to María Soledad Jiménez, Mycobacterial Laboratory of the Centro Nacional de Microbiología, Majadahonda, Madrid, for providing the microbiologic data.

Top

José Mayo, Julio Collazos, and Eduardo Martínez

Author affiliations: Hospital de Galdakao, Vizcaya, Spain

Top

References

  1. Nightingale  SD, Byrd  LT, Southern  PM, Jockusch  JD, Cal  SX, Wynne  BA. Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients. J Infect Dis. 1992;165:10825.PubMed
  2. Raszka  WV Jr, Skillman  LP, McEvoy  PL, Robb  ML. Isolation of nontuberculous, non-avium mycobacteria from patients infected with human immunodeficiency virus. Clin Infect Dis. 1995;20:736.PubMed
  3. Bessesen  MT, Shlay  J, Stone-Venohr  B, Cohn  DL, Reves  RR. Disseminated Mycobacterium genavense infection: clinical and microbiological features and response to therapy. AIDS. 1993;7:135761. DOIPubMed
  4. Lessnau  KD, Milanese  S, Talavera  W. Mycobacterium gordonae: a treatable disease in HIV-positive patients. Chest. 1993;104:177985. DOIPubMed
  5. Straus  WL, Ostroff  SM, Jernigan  DB, Kiehn  TE, Sordillo  EM, Armstrong  D, Clinical and epidemiologic characteristics of Mycobacterium haemophilum, an emerging pathogen in immunocompromised patients. Ann Intern Med. 1994;120:11825.PubMed
  6. Parenti  DM, Symington  JS, Keiser  J, Simon  GL. Mycobacterium kansasii bacteremia in patients infected with human immunodeficiency virus. Clin Infect Dis. 1995;21:10013.PubMed
  7. Chocarro  A, González-López  A, Breznes  MF, Canut  A, Rodríguez  J, Diego  JM. Disseminated infection due to Mycobacterium malmoense in a patient infected with human immunodeficiency virus. Clin Infect Dis. 1994;19:2034.PubMed
  8. Tchornobay  AM, Claudy  AL, Perrot  JL, Levigne  V, Denis  M. Fatal disseminated Mycobacterium marinum infection. Int J Dermatol. 1992;31:2867. DOIPubMed
  9. Schafer  RW, Sierra  MF. Mycobacterium xenopi, Mycobacterium fortuitum, Mycobacterium kansasii, and other nontuberculous mycobacteria in an area of endemicity for AIDS. Clin Infect Dis. 1992;15:1612.PubMed
  10. Valero  G, Peters  J, Jorgensen  JH, Graybill  JR. Clinical isolates of Mycobacterium simiae in San Antonio, Texas: an 11-yr review. Am J Respir Crit Care Med. 1995;152:15557.PubMed
  11. Roig  P, Nieto  A, Navarro  V, Bernacer  B, Borras  R. Micobacteriosis por Mycobacterium szulgai en paciente con infección por el virus de la inmunodeficiencia humana. Med Interna. 1993;10:1824.
  12. Tsukamura  M, Kita  N, Otsuka  W, Shimoide  H. A study of the taxonomy of the Mycobacterium nonchromogenicum complex and report of six cases of lung infection due to Mycobacterium nonchromogenicum. Microbiol Immunol. 1983;27:21936.PubMed
  13. Ridderhof  JC, Wallace  RJ Jr, Kilburn  JO, Butler  WR, Warren  NG, Tsukamura  M, Chronic tenosynovitis of the hand due to Mycobacterium nonchromogenicum: use of high-performance liquid chromatography for identification of isolates. Rev Infect Dis. 1991;13:85764.PubMed
  14. Lockwood  WW, Friedman  C, Bus  N, Pierson  C, Gaynes  R. An outbreak of Mycobacterium terrae in clinical specimens associated with a hospital potable water supply. Am Rev Respir Dis. 1989;140:16147.PubMed
  15. Peters  EJ, Morice  R. Miliary pulmonary infection caused by Mycobacterium terrae in an autologous bone marrow transplant patient. Chest. 1991;100:144950. DOIPubMed
  16. Ford  EG, Snead  SJ, Todd  J, Warren  NG. Strains of Mycobacterium terrae complex which react with DNA probes for M. tuberculosis complex. J Clin Microbiol. 1993;31:28056.PubMed

Top

Cite This Article

DOI: 10.3201/eid0401.980119

Related Links

Top

Table of Contents – Volume 4, Number 1—March 1998

Page created: December 13, 2010
Page updated: December 13, 2010
Page reviewed: December 13, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external